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Summary 
The induction of cell surface expression of class II major histocompatibility complex (MHC) 
antigens by interleukin (IL)-4 and interferon (IFN)-~/is inhibited by elevation of intraceUular 
cyclic (c)AMP,  which is caused by immunomodulatory agents such as E series prostaglandins 
(PGEs). To investigate the mechanism of this downregulation, we have analyzed the consequences 
of devating intracellular cAMP on cell surface expression,  mRNA levels, and promoter activity 
of the murine Ace and E/3 class II MHC genes. Elevation of cAMP resulted in a coordinate repression 
of both basal and inducible Ace and E/3 expression. 151 and 192 base pairs of Aol and E~/promoter 
sequence,  respectively, were sufficient for conferring repression by cAMP on a reporter gene. 
A mutational analysis of the Ac~ promoter revealed that CAMP downregulation is mediated by 
the conserved S and X1 DNA dements, which are also necessary for induction by cytokines. 
Downregulation by CAMP was not dependent on an intact X2 site, which is identical in sequence 
to the CILE dement which mediates the positive regulation of several genes by cAMP. These 
results identify the DNA dements which mediate repression of class II MHC genes by cAMP 
and show that the same DNA sequences can mediate both positive and negative regulation of 
class II MHC expression. 
ctivation of lymphocytes and macrophages is important 
in the pathogenesis of autoimmune disease. These acti- 
vated cells are found at inflammatory sites and synthesize 
numerous effector molecules, such as cytokines, proteases, and 
prostaglandins (1). An important molecular event in the ac- 
tivation of lymphocytes and macrophages is the induction 
of class II MHC antigens. Class II MHC antigens are cell 
surface heterodimeric proteins which present antigens to CD4 
positive T  lymphocytes and thus play a central role in the 
regulation of immune responses  (2). Class II is usually ex- 
pressed, at low levels, only on antigen presenting cells such 
as B lymphocytes or macrophages, and is induced by activating 
stimuli. Aberrant expression of class II can be induced on 
many cell types and is characteristic  of several autoimmune 
processes. For example, class II antigens are expressed on sy- 
noviocytes in rheumatoid arthritis and on renal tubule cells 
in autoimmune MRL/Ipr mice (3, 4). 
Class II MHC expression is usually coordinately regulated, 
primarily at the level of transcription of dass II MHC genes 
(reviewed in references 5 and 6). Most work has focused on 
understanding basal class II gene transcription and induction 
by activating signals. Class II genes are activated by many 
stimuli, including crosslinking of slg, 11.4, and LPS in B lym- 
phocytes and IFN-% TNF-c~, and granulocyte macrophage- 
CSF in macrophages. IFN-3' is the most potent inducer of 
aberrant class II gene expression. Work from many laborato- 
ries has shown that conserved DNA sequences, termed S (also 
known as W  or H), X1, X2, and Y boxes or elements, are 
present in all dass II gene promoters which have been se- 
quenced and are important for the basal expression and in- 
duction of class II genes. Several  genes encoding  DNA binding 
proteins which bind to the X1, X2, and Y elements have 
been cloned, but the mechanism of induction of class II genes 
is not known (5, 6). 
Physiologic mechanisms for the resolution of inflamma- 
tion are not well understood, but likely include deactivation 
and the prevention of activation of lymphocytes and macro- 
phages. An important component of deactivation would be 
downregulation or prevention of induction of class II expres- 
sion. Indeed, agents which suppress immune and inflamma- 
tory responses, such as TGF-3, glucocorticoids, and E series 
prostaglandins (PGEs) 1 (which act through elevation of in- 
1 Abbreviations used in this paper: CRE,  cAMP response element;  PGE, 
prostaglandin  E; PK-A, protein kinase A. 
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(5, 6). The mechanisms involved and the DNA elements which 
mediate negative regulation of class II are not known. PGEs 
and cAMP have been shown to prevent induction of cell sur- 
face expression  of class II by II.-4 and IFN-3, (7-9).  In addi- 
tion, cAMP has numerous suppressive effects on immune and 
inflammatory processes, including inhibition of T  lympho- 
cyte proliferation (10), inhibition of Ib2, IFN-3,, and TNF-o~ 
expression  (11-13),  and inhibition of expression  of the pro- 
tease stromelysin (14). This suggests that agents which in- 
crease intraceUular cAMP may be useful as therapeutic agents 
for autoimmune diseases, and, indeed, subcutaneous adminis- 
tration of PGEs resulted in increased survival in autoimmune 
MRL/Ipr  and NZB mice (15). 
Significant progress has been made over the last several  years 
in understanding the positive regulation of genes by cAMP. 
For several well studied genes, the stimulation of transcrip- 
tion by CAMP is mediated by a consensus DNA sequence 
TGACGTCA, termed the cAMP response  element (CRE). 
Transcription factor CRE-binding protein (CREB), which 
binds to the CILE, is phosphorylated after elevation of intra- 
cellular CAMP and activates transcription of cAMP inducible 
genes (16). The repression of several genes by cAMP has been 
described,  but the DNA sequences and transcription factors 
which mediate this effect have not been characterized (11-14, 
17). In this study, we investigated the coordinate repression 
of basal and IFN-7-induced expression of the murine Ao~ 
and EB class II MHC genes by cAMP.  We found that the 
proximal promoter sequences of both the Ac~ and EB genes 
were sufl~dent to mediate cAMP repression. Mutational anal- 
ysis of the Aot promoter revealed that the conserved S and 
X1 DNA elements which mediate basal expression  and in- 
duction of class II genes by cytokines also mediate repression 
of these genes by cAMP. Our data suggest that cAMP down- 
regulates dass II gene expression by inhibiting or altering 
positive transcription factors which bind to class II promoters 
and open a new avenue for investigating positive and nega- 
tive regulation of dass II genes. 
Materials and Methods 
Cell Lines.  Cell lines were grown in RPMI 1640 medium sup- 
plemented with 8% FCS, 100/~g/ml penicillin and streptomycin, 
and 10 -~ 2-ME. M12.4.1 cells are derived from a mature B cell 
lymphoma and P388D1 is a macrophage cell line, as previously  de- 
scribed (18). Both are of the d haplotype. 
Flow C2/toraetric Analysis.  Flow cytometric analysis was per- 
formed using a Becton Dickinson FACS analyzer (Becton Dick- 
inson and Co., Mountain View, CA). The following murine mAbs 
were  used: K24-199 (anti-FAce),  MK-D6 (anti-I-A~),  14-4-4 
(anti-I-Ece), 34-1-4 (anti-I-EB), 34-2-12 (anti-H-2D),  and 28-14- 
8 (anti-H-2L). The rat mAb directed against murine CD18, JB379, 
was the gift of Dr. T. Springer (Harvard University). Cells were 
washed with HBSS and incubated  with 30 #1 of  a previously  titrated 
mAb for 20 min on ice. Controls were performed using no pri- 
mary antibody or an isotype matched mAb directed against a non- 
crossreacting haplotype of I-A or H-2 proteins. Cells were then 
washed twice with FACS media (HBSS supplemented with 3% 
FCS and 0.1% Na azide) and incubated with fluorescein  conjugated 
goat F(ab)z fragment  anti-mouse  or anti-rat immunoglobulin 
(Cappel). After two washes with FACS  media, cells  were analyzed 
on the FACS analyzer. 
Pre~ration of Cellular RNA  and Northern Hybridization Anal- 
ysis.  Total  cellular RNA was isolated after disruption of cells in 
4.4 M guanidium isothiocyanate  and extraction with acid-phenol 
exactly  as described (19). 20/~g of RNA were fractionated  on 1.2% 
formaldehyde agarose gels and transferred to Nytran membranes 
(Schleicher and Schuell, Keene, NH). The membranes were then 
prebybridized, hybridized, and washed as recommended by the 
manufacturer. Hybridization  was  with nick  translated cDNA 
probes: I-Ace 1.3-kb Hind III fragment (18), I-E~ 0.5-kb Pst I frag- 
ment (20), and A50 0.9-kb Pst I fragment (21). 
Plasmids and Mutagenesis.  Standard  recombinant technology  was 
used (22). PCR was used to amplify promoter sequences corre- 
sponding to base pairs -151  to  +48 of the Ace  ~ promoter and 
-192 to  +44 of the E#  a promoter from subcloned genomic se- 
quences (20, 23). Nudeotide positions in the Ace promoter are num- 
bered according to reference 24.  The PCR primers introduced 
unique Hind IlI and Xba I restriction endonuclease sites which 
allowed subcloning of these promoter fragments into vector Basic 
CAT (Promega), which contains the CAT gene but no promoter 
or enhancer sequences. The nucleotide sequence of both strands 
of each insert was confirmed using the dideoxynucleotide  method 
with Sequenase, as recommended by the manufacturer (U.S. Bio- 
chemical). 
Deletion mutations of the Ace promoter were obtained by using 
PCR to amplify appropriate sequences. In each case, an Xba I site 
was introduced at the same 3' end and a Hind III site was intro- 
duced at the appropriate 5' end. Substitution mutations of the Ace 
promoter were obtained by using PCR to amplify two DNA frag- 
ments which when cut with Xho I and ligated, reconstitute the 
Ace promoter sequences -151  to  +48 with the appropriate base 
substitutions and with Hind Ill and Xba I ends. The DNA frag- 
ments generated by PCR were subcloned into vector Basic-CAT 
and the nucleotide sequence of both strands of each insert was 
confirmed. The sequences of PCR primers used are available on 
request. The plasmid RSV-CAT was the gift of  Dr. P. Mellon (Salk 
Institute). 
The expression  phsmid CMVCCe  expressing the catalytic  subunit 
of protein kinase A driven by the CMV promoter was the gift of 
Dr. M. Uhler (University of Michigan Medical Center). The con- 
trol expression  plasmid  CMVCCeA  was constructed by deleting 400 
bp of catalytic subunit coding sequence by cutting with Bgl II, 
filling in the recessed termini with the Klenow fragment of DNA 
polymerase I, and religating. 
Transfections.  M12.4.1 and P388D1 cells were transfected  using 
the DEAE-dextran  method as previously  described (25). All samples 
were done in duplicate and tested in at least three independent ex- 
periments. Pilot experiments showed that normalization for trans- 
fection efficiency  using cotransfected plasmid pCH110 encoding 
B-galactosidase was equivalent to normalizing for protein content 
of extracts. Subsequent transfections were normalized for protein 
content using a commercially available kit (Biorad). Each sample 
was trausfected with a total of 12.5 #g of DNA in a 2:1 molar 
ratio of expression plasmid: reporter plasmid. 8-Br cAMP (Sigma 
Chemical Co., St. Louis, MO) was added to appropriate samples 
at a final concentration of 1 mM 2 h post transfection. IFN-7 
(Amgen) was added to a final concentration of 10 U/m124 h after 
transfection. M12.4.1 cells were harvested 48 h after transfection 
and P388D1 cells harvested 72 h after transfection, and CAT ac- 
tivity was assayed  and quantified using thin layer  chromatography 
and liquid scintillation counting as described (25). 
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Figure 1.  Flow cytometric analysis of M12.4.1 cells cultured with 8-Br cAMP. M12.4.1 B lymphoma cells (d haplotype) were analyzed for ce~l surface 
expression of class II MHC (I-A) and class I MHC (H-2) molecules using routine lAbs, and for CD18 expression using a rat mAb (as detailed in 
Materials and Methods).  Fluorescein conjugated goat F(ab)2 fragments anti-mouse or anti-rat immunoglobulin  were used as secondary reagents. In 
control samples no primary antibody or an irrelevant primary antibody of the same isotype were used. Identical results were obtained and only one 
set of control histograms is shown.  M12.4.1 cells were analyzed after growth for 7 d in media alone (  ) or with 1 mM 8-Br cAMP (  ). 
Results 
Increased Intracelhlar cAMP Decreases Cell Surface Expres- 
sion of Class II Major Histocompatibility Complex  Proteins. 
Previous results demonstrated that cAMP prevented induc- 
tion of cell surface expression of class II proteins by Ib4 and 
IFN-7 (7-9). In order to simplify the analysis of this repres- 
sive effect, we wished to determine if CAMP also decreased 
constitutive class II cell surface expression. The class II MHC 
positive M12.4.1  B cell line was cultured in the presence of 
1 mM 8-Br cAMP (a cAMP analog which is not a substrate 
for phosphodiesterase)  and surface expression of the four "clas- 
sical" class II MHC proteins (Aol, A~/, E~, E/~) was ana- 
lyzed (Fig.  1). Surface expression of aU four class II proteins 
was significantly reduced by treatment with 8-Br CAMP. The 
low level of background staining also decreased upon treat- 
ment with 8-Br cAMP, but to a lesser extent than class II 
specific staining. Thus, a significant number of treated cells 
were class II negative (the dotted curves overlap significantly) 
while untreated ceUs were mostly class II bright (the peaks 
of the solid curves are nonoverlapping). The low level of  back- 
ground staining was seen only when a routine (and not rat; 
see Fig. 1, CD18 panel) secondary FITC antibody was used, 
and most likely reflects the direct binding of routine secondary 
antibody to surface IgG (L. Ivashkiv, unpublished data). How- 
ever, because of the change in background, we wished to fur- 
ther explore the specificity of the downregulation of cell sur- 
face class II molecules, and therefore determined the M12.4.1 
cell surface expression of class I and CD18 proteins after 8-Br 
cAMP treatment (Fig. 1). Unlike class II, cell surface expres- 
sion of class I H-2L and H-2D did not decrease any more 
than background after 8-Br cAMP treatment, and cell sur- 
face expression of CD18 (detected with a rat lab)  was actu- 
ally slightly induced. Therefore, treatment of M12.4.1  cells 
with 8-Br CAMP results in a specific and coordinate down- 
regulation of cell surface class II molecules. 
Decreased Cell Su~ace Expression of Class II Is Associated with 
a Decrease  in mRNA.  We determined the effect of 8-Br cAMP 
on class II MHC Ac~ and E~/mRNA levels using Northern 
blot hybridization (Fig.  2). Ac~ and EB mRNA levels were 
significantly diminished after 8-Br CAMP treatment, but the 
mRNA levels for the A50 control housekeeping gene did 
not change significantly. Ac~ and EB mRNA levels increased 
after the media was changed and the 8-Br cAMP was removed 
(Fig. 2, lane 3). Thus, the cAMP induced decrease in surface 
expression of class II correlates with a decrease in levels of 
dass II mRNA. 
Proximal Promoter Sequences of the Act and F~ genes Are 
Su.~cient for Repression by cAMP and Protein Kinase A.  To 
determine the effect of cAMP on class II gene promoter ac- 
tivity, we fused promoter sequences containing 151 bp of 5' 
flanking A~  k DNA (23,  24)  and 192 bp of 5' flanking Ea  d 
DNA (20) to the bacterial CAT reporter gene in the vector 
Basic-CAT (Fig. 3 A). These constructs are similar to those 
used to study the cytokine inducibility of these genes (5, 6, 
24) and transcription has been shown to initiate accurately 
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with cAMP. RNA was isolated from M12.4.1 cells after 7 d of treatment 
with 1 mM 8-Br cAMP and 2 d after 8-Br cAMP was removed. 20 #g 
of RNA were fractionated on 1.2% formaldehyde agarose gels, blotted, 
and the same membrane sequentially hybridized with radiolabeled cDNA 
probes encoding Act, EB, or the housekeeping gene A50. 
(M. Z. Whitley, unpublished  data). Promoter activity was 
measured by transfecting the Ac~151-CAT and E~192-CAT 
constructs into M12.4.1 cells and assaying CAT activity. The 
constructs containing Aot and EB promoter sequences  resulted 
in dramatically  higher CAT actMty than the Basic-CAT  vector 
in M12.4.1 cells (Fig. 3 B,  lanes I, 3,  and 5) and this  in- 
creased activity was cell type specific  and correlated with en- 
dogenous class II MHC gene expression (not shown). Incu- 
bation of transfected M12.4.1 ceils with 8-Br CAMP resulted 
in a 72.9% and 82.3% decrease in the activity of the Aot151- 
CAT and E3192-CAT constructs, respectively,  but not of the 
RSV-CAT control (Fig. 3 B shows a representative experi- 
ment; % repression are those calculated based on duplicate 
samples tested in at least three independent experiments). 
cAMP acts by binding to the regulatory subunit  of pro- 
tein kinase A (PK-A) and causing the release of free catalytic 
subunit.  A common experimental approach for mimicking 
elevations in intraceUular CAMP is to overexpress free PK-A 
catalytic subunit.  Fig. 3 C shows the results of cotransfec- 
tions of M12.4.1 cells with reporter constructs and an ex- 
pression plasmid encoding PK-A catalytic subunit.  Overex- 
pression of the catalytic subunit (+ PK-A) resulted in a >85% 
reduction of Aot151-CAT and E/3192-CAT activity, but not 
of the RSV-CAT control.  (Control  lanes [-PK-A]  were 
cotransfected with the same expression plasmid encoding a 
mutated catalytic subunit). These experiments show that the 
Aot151-CAT and E3192-CAT reporter genes accurately  reflect 
the regulation of  endogenous class II genes and that the prox- 
imal promoter sequences  of  the Ac~ and EB genes are sufficient 
to confer repression by cAMP onto a reporter gene. 
We also tested the ability of protein kinase A to repress 
the IFN-'y-induced activity of  Aot151-CAT and E3192-CAT 
in the macrophage-like P388D1 cell line (Fig. 4). CAT ac- 
tivity in cells transfected with Ac~151-CAT or E3192-CAT 
was induced 22.7-fold and 26.0-fold, respectively, by IFN-3', 
consistent with data from other laboratories (5, 6). Activity 
of the plasmid Basic-CAT, which does not contain any class 
II promoter sequences, was not affected by IFN-3, (Fig. 4, 
lanes I and 2). Cotransfection with PK-A resulted in a 60% 
inhibition of IFN-'y-mediated  induction of Ac~151-CAT and 
a 78%  inhibition of the induction of E3192-CAT activity. 
Thus the class II proximal promoter sequences  mediate cAMP 
repression of  both basal and inducible class II expression, and 
this  effect is evident in two different cell lines. 
Mutagenesis of  Ac~ Promoter  and Analysis tithe Effect of  De- 
letion and Substitution Mutations on Basal Ac~ Promoter Ac- 
tivity.  We wished to identify the DNA sequences or tran- 
scription  elements  within a class II gene promoter which 
mediate repression  by cAMP. We used PCR to generate panels 
of deletion and substitution  mutations in the Ac~ promoter. 
The details of construction are described in Materials and 
Methods.  Fig. 5 shows the wild type Ao~ promoter and the 
mutations which were created. The S (also termed W or H; 
reference 24), X1, X2, and Y elements are present in all class 
II gene promoters and their function in basal and inducible 
promoter activity has been well documented (5, 6). In addi- 
tion, the Aot promoter contains the Z motif and a putative 
NF-xB binding site whose role in class II expression is not 
well characterized (24). Mutations were constructed such as 
to sequentially delete one or two known functional elements. 
Substitution  mutations were introduced into the S, X1, X2, 
and Y elements; an additional construct contains substitu- 
tion mutations in both S and X1 elements  (Fig. 5). 
M12.4.1 cells were transfected with wild type and mutant 
constructs  and CAT activity was assayed. Fig. 6 shows the 
effect of the mutations on CAT activity. These results agree 
in general with the analysis of the A~  a promoter by Dedrick 
and Jones (24) and provide new information about the effects 
of mutation of only the X2 element and double mutations 
of both S and X1.  Small differences from the Dedrick and 
Jones data (24) are most likely secondary to differences in 
exact constructs and mutations created, but may be secondary 
to using a different cell line or to haplotype  specific differ- 
ences in promoter activity  (26). 
The Conserved  S and X1 Promoter  Elements Mediate Repres- 
sion of  Ac~ Promoter  Activity by cAMP..  The various Ao~ pro- 
moter deletion and substitution mutants were assayed  for their 
ability to be repressed by cAMP. M12.4.1 ceils were cotrans- 
fected with promoter constructs and expression plasmids en- 
coding wild type or mutant PK-A and CAT activity was as- 
sayed. The results have been normalized  to the amount of 
repression seen with the wild type plasmid Aot151-CAT in 
each experiment. This was done to facilitate  averaging  of  results 
from several  experiments, since  the percent repression of the 
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A can repress the activity of reporter 
plasmids containing  class  II MHC gene 
promoters.  (A) The structure  of the 
A(x151-CAT and E~192-CAT reporter 
cont~inln~  class II Aol and E/3 promoter 
sequences subcloned into vector Basic- 
CAT. The S (also termed W or H; refer- 
ences 5 and 24), X1, X2, and Y ele- 
ments are conserved sequences  found in 
an  class II MHC promoters. (/3)  M12.4.1 
B lymphoma cells  were transfected  with 
reporter  constructs  and  appropriate 
samples were treated with I mM 8-Br 
cAMP beginning 2 h  after infection. 
Cells were harvested 48 h post trans- 
fection and CAT activity assayed  by thin 
layer chromatography  and liquid scin- 
tiUatinn counting. (C)  M12.4.1 ceils 
were cotransfected with reporter con- 
structs and a twofold molar excess of 
an expression plasmid encoding wild 
type ( + PK-A)  or mutated ( - PK-A)  pro- 
tein kinase A catalytic subunit. B and 
C show ~presentative experiments.  The 
values for  %  repression  _+  SE were 
calculated using data  from  duplicate 
samples from at least three independent 
experiments.  NA  =  no  significant 
repression of the low level  CAT activity 
generated by Basic-CAT was detected. Figure 4.  Protein kinase A inhibits the induction of class II MHC Ac~ and EB promoter activity by IFN-7. The P388D1 macrophage cell line 
was cotransfected with reporter  constructs  and a two-fold molar excess of an expression plasmid encoding wild type (+PK-A) or mutated (-PK-A) 
protein  kinase A catalytic subunit, rlFN-  7  (Amgen) was added to a final concentration of 10 U/ml 24 h post transfection and cells were harvested 
72 h post transfection and CAT activity assayed. A representative experiment is shown; values for fold reduction _+ SE and % repression were calculated 
using data from duplicate samples from at least three independent experiments. NA  =  No significant induction of low level  CAT activity generated 
by Basic-CAT was detected. 
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Figure S.  Mutagenesis of the class II MHC A~ promoter.  (.4) Struc- 
ture of constructs containing  progressive deletions of 5' flanking A~ se- 
quence. The S (also termed W  or H; reference 24), X1, X2, and Y ele- 
ments are conserved sequences found in all class II MHC gene promoters. 
(B) Substitution mutations in the A~ promoter. A~ 5' flanking sequence 
from  -110 to  -38 and specific nucleotide substitutions introduced into 
the S, X1, X2, and Y elements are shown. Substitution mutations were 
made in the context of the Ard51-CAT construct.  All constructs  were 
verified by sequencing of both strands. 
Aod51-CAT construct varied slightly from one experiment 
to the next (range 84.6-89.3%). 
Fig. 7 shows the analysis  of  the deletion mutations. A con= 
struct which contains 114 bp of  5' flanking sequence  was fully 
repressed by PK-A, but deletions of the S element (compare 
Ao~l14-CAT to Aol90-CAT) and X elements (compare AoLg0- 
CAT to Ac~63-CAT)  progressively diminished the ability of 
PK-A to repress promoter activity. Three lines of reasoning 
suggest that this effect is not merely secondary to the lower 
basal activity of the deleted constructs:  (a) deletion of the 
Z and KB elements significantly lowered basal activity but 
did not affect repression. (b) There was no common baseline 
level to which all constructs are repressed; instead, the level 
of CAT activity under  +PK-A conditions  varied according 
to construct (a combination of data in Figs. 6 and 7,  not 
shown). (c) When upstream sequences  were deleted, the Ac~63 
construct, which had the lowest basal activity, was actually 
induced by PK-A. Thus, these results suggest that the con- 
served S and X promoter elements mediated repression by 
PK-A. To confirm this, we tested the panel of substitution 
mutations (Fig. 8). Mutations in the S and X1 elements, but 
not the X2 element (which matches a consensus CRE), de- 
creased  repression by PK-A to 59.2% and 37.4%, respectively, 
of the repression seen with the wild type promoter. The Y 
element mutation decreased promoter activity to a low level 
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Figure 6.  Effect of deletion and substitution mutations on basal expres- 
sion of AoeCAT plasmids in M12.4.1  B  lymphoma cells.  M12.4.1  cells 
were transfected with reporter plasmids and CAT activity assayed.  Each 
plasmid was assayed in duplicate in at least three independent  transfec- 
tions. The data is shown as mean CAT activity _+ SE relative to the ACt151- 
CAT reference construct (100%  activity).  Absolute %  conversion with 
ACt151-CAT was in the range of 30-50%, and in some experiments more 
extract from cells transfected with mutant constructs was used to increase 
the absolute %  conversion. (A) Relative CAT activity generated by Act 
promoter deletion mutations. (B) ILelative CAT activity generated by sub- 
stitution mutations in Act151-CAT. 
such that any repression could not be accuratdy assayed (see 
Fig. 6). A double mutation, in both the S and Xl elements, 
completely eliminated repression by PK-A,  even though it 
did not depress basal activity significantly bdow that  seen 
with either the single S or X1 mutations. These results show 
that the S and X1 promoter elements together mediate the 
repression  of promoter  activity by PK-A. 
Discussion 
Intracdlular cAMP levds in lymphocytes and macrophages 
are elevated by several immunomodulatory stimuli, such as 
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Figure 7.  The effect of progressive 5' deletions on the ability of protein 
kinase A to repress the Act class II MHC gene promoter. M12.4.1 B lym- 
phoma cells were cotransfected with reporter constructs and a two-fold 
molar excess of an expression plasmid encoding wild type or mutated pro- 
rein kinase A catalytic subunit and CAT activity was assayed.  The abso- 
lute %  conversion with Aot151-CAT was in the range of 30-50%,  and 
in most experiments, more extract from cells transfected with mutant con- 
structs was used to increase the absolute % conversion. The data is shown 
as the mean %  repression _+ SE of each construct relative to the repression 
of the reference construct Aot151-CAT (100%).  The absolute repression 
of Act151-CAT was 87.6  +_  1.5%. Each construct was tested in duplicate 
in at least three independent experiments.  *  The ACt63-CAT construct 
was not repressed by PK-A, but instead CAT activity was induced by 21.8 
-+  6.3%. 
PGEs, crosslinking of Fc receptors, and crosslinking of cell 
surface class II antigens (7-9, 27, 28). cAMP mediated  fig- 
naling has numerous suppressive  effects on immune and inflam- 
matory  processes,  including inhibition  of T  lymphocyte 
proliferation,  inhibition of induction of class II expression 
by  IL-4 and  IFN-%  and  inhibition of the  expression  of 
cytokines such as IL-2, IFN-3,, and TNF-cr (7-14, 27, 28). 
An understanding of the mechanism by which cAMP sup- 
presses class II and cytokine expression  would be useful in 
developing therapeutic approaches to suppressing inflamma- 
tion. In this study,  we undertook an initial analysis of the 
mechanism by which cAMP represses class II MHC expres- 
sion. We chose to study class II because the cAMP mediated 
inhibition of induction of cdl surface expression  of class II 
has been well described,  including experiments done with 
whole animals, and because of the importance of class II in 
regulating immune responses and its aberrant expression in 
autoimmune disease (1, 2, 7-9). In addition, class II MHC 
gene promoters  contain a conserved X2 site, which is iden- 
tical  or similar to the CtLE,  and thus it was possible that 
this element might mediate the regulation of class II by cAMP. 
Our resuhs show that CAMP downregulates basal as weU 
as inducible cell surface expression  of dass II antigens. This 
downregulation is coordinate for the four "classical" murine 100 
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Figure 8.  The S and X1 elements mediate the repression  of the Ac~ 
promoter by protein kinase A. M12.4.1  B lymphoma cells were cotrans- 
fected with reporter constructs and a two-fold molar excess of an expres- 
sion plasmid encoding wild-type or mutated protein kinase A catalytic 
subunit and CAT activity was assayed. The absolute % conversion with 
Arq51-CAT was in the range of 30-50%, and in most experiments, more 
extract from cells transfected with mutant constructs was used to increase 
the absolute % conversion.  The data is shown as the mean % repression 
+/-  SE of each construct relative to the repression  of the reference con- 
struct Aod51-CAT (100% repression).  The absolute repression of Ac~151- 
CAT was 87.6  _+  1.5%.  Each construct was tested in duplicate in at least 
three independent experiments. NT  =  The basal CAT activity generated 
by the construct with a mutated Y box was too low to allow a determina- 
tion of repression.  * The construct with both S and X1 elements mutated 
was not repressed by PK-A, but instead CAT activity was induced by 26.6 
+_  5.2%. 
class II proteins  (Figs. 1 and 2), and is also seen with the 
human DRce gene (L. Ivashkiv and H.-C. Liou, unpublished 
data). The repression of class II expression correlates with 
a decrease in class II mRNA levels. Our observation that 151 
and 192 bp of Ac~ and E3 promoter sequence, respectively, 
can confer repression by cAMP on a reporter gene suggests 
that repression by cAMP occurs, at least in part, at the level 
of transcription.  This is supported by a mutational analysis 
of the Ac~ promoter. 
The mutational analysis of the Ace promoter utilized both 
progressive 5' deletions and substitution mutations. The sub- 
stitution mutations were designed such as to introduce dis- 
crete 5-8 bp changes into known transcription elements which 
have been defined in many laboratories, including our own, 
using functional,  protein-binding,  and in vivo footprinting 
approaches (5, 6, 24, 29). The effects of mutations on basal 
Aoe promoter activity are in general agreement with the data 
of Dedrick and Jones (24), with small differences most likely 
explained by the differences in exact site and sequence of in- 
troduced mutations.  Our data extend previous observations 
by demonstrating that an X2 site mutation which leaves the 
X1 element intact diminishes basal promoter activity by 83% 
and by showing that effects of simultaneous  mutations in 
the S and X1 elements diminish basal promoter activity only 
slightly more than single S or X1 element mutations. 
Analysis using the deletion mutants showed that 114 bp 
of upstream Ao~ sequence were sufficient for full repression 
by PK-A. Deletion of the S and X  elements resulted in a 
progressive diminution of repression by PK-A, to the point 
where a construct which contains only an intact Y box was 
slightly  inducible.  Analysis using  substitution  mutations 
showed that individual mutations in the S and X1 elements 
partially decreased  repression by PK-A (by 40.8% and 62.6%; 
Fig. 8). A construct containing mutations in both S and X1 
elements did not repress at all, but instead was slightly in- 
duced by PK-A. Therefore the S and X1 dements, which are 
found in tandem in all class II MHC promoters sequenced 
so  far, mediate  the  repression  of the  Ace  promoter  by 
cAMP/PK-A. This is reminiscent of the cytokine induction 
of class II genes, for which three elements, the S, X1, and 
Y boxes, are required. Our Y box mutation resulted in such 
low promoter activity that its effect on repression by PK-A 
could not be tested. However, constructs which contained 
intact Y boxes (Ao163-CAT, Fig. 7; S+X1 MUT, Fig. 8) were 
not repressed  at all by PK-A, suggesting that the Y box cannot 
act independently to mediate repression by PK-A. 
The X region of class II MHC promoters has only recently 
been subdivided into adjacent X1 and X2 sites. The X1 site 
binds proteins  such as RF-X and NF-X  (30, 31), whereas 
the X2 site is related to the CRE,  and binds transcription 
factors of the CREB/ATF  family such as mXBP and hXBP 
(32, 33). Our data demonstrate that the X1 and X2 sites differ 
functionally in their ability to mediate responses to cAMP, 
and thus support the subdivision of  the X box into two adja- 
cent sites. A surprising result was that regulation of the Ace 
gene by cAMP was not mediated by the X2 site, a perfect 
CRE, but instead was mediated by the S and Xl elements. 
cAMP effects are not necessarily mediated by CREs, as an 
AP-2 site can confer cAMP inducibility on a gene (34), and 
CREs do not always function in cAMP induction, but can 
serve as basal transcription elements (35) or can mediate re- 
sponses to elevations in intracellular calcium (36). 
Our data suggest that the repression of the Ace promoter 
by cAMP is mediated by proteins which bind to the S (24) 
and Xl elements (such as RF-X, NF-X) or proteins which 
do not directly contact DNA but interact  with S and X1 
binding proteins. Our initial analysis of the effect of CAMP 
on nuclear protein binding to the Aoe S and X1 sites has been 
hampered by the low affinity of this interaction  compared 
to the high affinity binding to the X2 site (reference 24; L. 
Ivashkiv, unpublished  data). Experiments  utilizing in vivo 
footprinting (29) should provide additional information about 
the effects of cAMP  on  binding  of proteins  to  the  Ac~ 
promoter. 
In conclusion, our study identifies two tandem DNA se- 
quences, the S and X1 sites, which mediate the repression 
of the Ace class II MHC gene by cAMP/protein kinase A. 
To the best of our knowledge, this is the first identification 
of DNA elements which can mediate repression by cAMP. 
The promoters of other genes which are repressed by cAMP, 
such as stromelysin,  I1.-2, and TNF-Ce do not contain any 
obvious homologies to the S and X1 sequences. This sug- 
gests that cAMP acts upon a factor which does not directly 
1590  Cyclic  AMP Represses  Class  II Major Histocompatibility Complex Genes contact DNA, but instead interacts with different proteins 
of variable DNA binding specificity. This is reminiscent of 
the induction of class II genes by cytokines such as IFN-% 
Indeed, the same S and X1 DNA elements can mediate both 
positive regulation by IFN-'y and TNF-a (5, 6, 37) and nega- 
tive regulation by cAMP. Therefore, a better understanding 
of the mechanism of negative regulation by cAMP may also 
yield insight into positive regulation by cytokines. 
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